Skip to main content
Learn more about the Pediatric Translational Research Program at the Herman B Wells Center for Pediatric Research.

Pediatric Translational Research

Group photo of 17 Gaston Lab group members posed outside with IU School of Medicine campus and Indianapolis skyline in the background

The Pediatric Translational Research program is focused on using lab discoveries to develop treatments and diagnostics that will help children and young adults in the clinical setting. These include respiratory conditions such as asthma, severe asthma, bronchopulmonary dysplasia, opioid-induced respiratory depression, primary ciliary dyskinesia, cystic fibrosis and aerodigestive disorders.

Members of this group and their colleagues have discovered exciting pathways leading to the development of several treatments and diagnostic modalities that are being evaluated for use in each of these areas. A few of these treatments and modalities have reached the clinical study phase of research, which includes adults as well.

Patient and clinician from the Pediatric Translational Research group

A major goal of this program is to help pediatric investigators across all disciplines at the Wells Center to collaborate with engineers and other scientists, translating new insights and discoveries into products that will improve the health of children.

Learn more about the group's research

Featured News

Researchers awarded $12 million to pursue personalized therapies for severe asthma

A group of researchers led by Indiana University School of Medicine’s Benjamin Gaston, MD, has been awarded a research program project grant (P01) from the National Heart, Lung and Blood Institute. The award amounts to just over $12 million over the next five years and will fund the development of personalized therapeutic approaches for severe asthma.

IU School of Medicine  |  Oct 18, 2021